Anke J. Roelofs
- Oncology top 2%
- Molecular Biology top 10%
- Rheumatology top 1%
- Orthopedics and Sports Medicine top 1%
- Surgery top 10%
- Co-authors
- Michael J. RogersCosimo De BariKeith ThompsonSharon GordonFrank H. EbetinoFraser P. CoxonHannu MönkkönenMarjo Jauhiainen
- Topics
- Bone health and treatments (21 papers)Osteoarthritis Treatment and Mechanisms (14 papers)Radiopharmaceutical Chemistry and Applications (8 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Anke J. Roelofs
48 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 110
- Oncology 1.4k
- Molecular Biology 858
- Rheumatology 737
- Orthopedics and Sports Medicine 715
- Surgery 372
Countries citing papers authored by Anke J. Roelofs
This map shows the geographic impact of Anke J. Roelofs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke J. Roelofs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke J. Roelofs more than expected).
Fields of papers citing papers by Anke J. Roelofs
This network shows the impact of papers produced by Anke J. Roelofs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke J. Roelofs. The network helps show where Anke J. Roelofs may publish in the future.
Co-authorship network of co-authors of Anke J. Roelofs
This figure shows the co-authorship network connecting the top 25 collaborators of Anke J. Roelofs. A scholar is included among the top collaborators of Anke J. Roelofs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke J. Roelofs. Anke J. Roelofs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 5 | |
| 4 | 39 | |
| 5 | 12 | |
| 6 | 48 | |
| 7 | 34 | |
| 8 | 66 | |
| 9 | 52 | |
| 10 | 44 | |
| 11 | 8 | |
| 12 | 3 | |
| 13 | 56 | |
| 14 | 139 | |
| 15 | 114 | |
| 16 | 21 | |
| 17 | 232 | |
| 18 | 190 | |
| 19 | 18 | |
| 20 | Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation | 1 |
About Anke J. Roelofs
Anke J. Roelofs is a scholar working on Rheumatology, Oncology and Orthopedics and Sports Medicine, having authored 49 papers that have together received 2.9k indexed citations. Recurring topics across this work include Bone health and treatments (21 papers), Osteoarthritis Treatment and Mechanisms (14 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). The work is most often cited by research in Orthopedics and Sports Medicine (715 citations), Oncology (1.4k citations) and Rheumatology (737 citations). Anke J. Roelofs has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Michael J. Rogers, Cosimo De Bari, Keith Thompson, Sharon Gordon, Frank H. Ebetino, Fraser P. Coxon, Hannu Mönkkönen, Marjo Jauhiainen, Jukka Mönkkönen and Sharon Ansboro. Their work appears in journals such as Nature Communications, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.